The global AI-Powered Drug Discovery Software market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
AI-Powered Drug Discovery Software is a software system that uses artificial intelligence technology for drug discovery and development. It uses advanced artificial intelligence algorithms and technologies such as machine learning, deep learning, and data mining to help drug researchers perform data analysis, prediction, and optimization during the drug discovery process.
This report includes an overview of the development of the AI-Powered Drug Discovery Software industry chain, the market status of Pharmaceutical Company (On-Premise, Cloud-Based), Academic Research Institution (On-Premise, Cloud-Based), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of AI-Powered Drug Discovery Software.
Regionally, the report analyzes the AI-Powered Drug Discovery Software markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global AI-Powered Drug Discovery Software market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the AI-Powered Drug Discovery Software market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the AI-Powered Drug Discovery Software industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., On-Premise, Cloud-Based).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the AI-Powered Drug Discovery Software market.
Regional Analysis: The report involves examining the AI-Powered Drug Discovery Software market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the AI-Powered Drug Discovery Software market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to AI-Powered Drug Discovery Software:
Company Analysis: Report covers individual AI-Powered Drug Discovery Software players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards AI-Powered Drug Discovery Software This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Company, Academic Research Institution).
Technology Analysis: Report covers specific technologies relevant to AI-Powered Drug Discovery Software. It assesses the current state, advancements, and potential future developments in AI-Powered Drug Discovery Software areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the AI-Powered Drug Discovery Software market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
AI-Powered Drug Discovery Software market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
On-Premise
Cloud-Based
麻豆原创 segment by Application
Pharmaceutical Company
Academic Research Institution
Others
麻豆原创 segment by players, this report covers
AtomWise
AutoDock
BenevolentAI
CCD Vault
Compound Assist
Cyclica
DrugDev Spark
DrugPatentWatch
DSG Drug Safety
Epocrates
InSilicoTrials
Insilico Medicine
Micro Tracker
PEPID PDC
厂肠丑谤枚诲颈苍驳别谤
Thermo Scientific
XtalPi
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI-Powered Drug Discovery Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI-Powered Drug Discovery Software, with revenue, gross margin and global market share of AI-Powered Drug Discovery Software from 2019 to 2024.
Chapter 3, the AI-Powered Drug Discovery Software competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and AI-Powered Drug Discovery Software market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI-Powered Drug Discovery Software.
Chapter 13, to describe AI-Powered Drug Discovery Software research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of AI-Powered Drug Discovery Software
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of AI-Powered Drug Discovery Software by Type
1.3.1 Overview: Global AI-Powered Drug Discovery Software 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global AI-Powered Drug Discovery Software Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 On-Premise
1.3.4 Cloud-Based
1.4 Global AI-Powered Drug Discovery Software 麻豆原创 by Application
1.4.1 Overview: Global AI-Powered Drug Discovery Software 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical Company
1.4.3 Academic Research Institution
1.4.4 Others
1.5 Global AI-Powered Drug Discovery Software 麻豆原创 Size & Forecast
1.6 Global AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast by Region
1.6.1 Global AI-Powered Drug Discovery Software 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global AI-Powered Drug Discovery Software 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America AI-Powered Drug Discovery Software 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe AI-Powered Drug Discovery Software 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific AI-Powered Drug Discovery Software 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America AI-Powered Drug Discovery Software 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa AI-Powered Drug Discovery Software 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 AtomWise
2.1.1 AtomWise Details
2.1.2 AtomWise Major Business
2.1.3 AtomWise AI-Powered Drug Discovery Software Product and Solutions
2.1.4 AtomWise AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 AtomWise Recent Developments and Future Plans
2.2 AutoDock
2.2.1 AutoDock Details
2.2.2 AutoDock Major Business
2.2.3 AutoDock AI-Powered Drug Discovery Software Product and Solutions
2.2.4 AutoDock AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 AutoDock Recent Developments and Future Plans
2.3 BenevolentAI
2.3.1 BenevolentAI Details
2.3.2 BenevolentAI Major Business
2.3.3 BenevolentAI AI-Powered Drug Discovery Software Product and Solutions
2.3.4 BenevolentAI AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 BenevolentAI Recent Developments and Future Plans
2.4 CCD Vault
2.4.1 CCD Vault Details
2.4.2 CCD Vault Major Business
2.4.3 CCD Vault AI-Powered Drug Discovery Software Product and Solutions
2.4.4 CCD Vault AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 CCD Vault Recent Developments and Future Plans
2.5 Compound Assist
2.5.1 Compound Assist Details
2.5.2 Compound Assist Major Business
2.5.3 Compound Assist AI-Powered Drug Discovery Software Product and Solutions
2.5.4 Compound Assist AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Compound Assist Recent Developments and Future Plans
2.6 Cyclica
2.6.1 Cyclica Details
2.6.2 Cyclica Major Business
2.6.3 Cyclica AI-Powered Drug Discovery Software Product and Solutions
2.6.4 Cyclica AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Cyclica Recent Developments and Future Plans
2.7 DrugDev Spark
2.7.1 DrugDev Spark Details
2.7.2 DrugDev Spark Major Business
2.7.3 DrugDev Spark AI-Powered Drug Discovery Software Product and Solutions
2.7.4 DrugDev Spark AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 DrugDev Spark Recent Developments and Future Plans
2.8 DrugPatentWatch
2.8.1 DrugPatentWatch Details
2.8.2 DrugPatentWatch Major Business
2.8.3 DrugPatentWatch AI-Powered Drug Discovery Software Product and Solutions
2.8.4 DrugPatentWatch AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 DrugPatentWatch Recent Developments and Future Plans
2.9 DSG Drug Safety
2.9.1 DSG Drug Safety Details
2.9.2 DSG Drug Safety Major Business
2.9.3 DSG Drug Safety AI-Powered Drug Discovery Software Product and Solutions
2.9.4 DSG Drug Safety AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 DSG Drug Safety Recent Developments and Future Plans
2.10 Epocrates
2.10.1 Epocrates Details
2.10.2 Epocrates Major Business
2.10.3 Epocrates AI-Powered Drug Discovery Software Product and Solutions
2.10.4 Epocrates AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Epocrates Recent Developments and Future Plans
2.11 InSilicoTrials
2.11.1 InSilicoTrials Details
2.11.2 InSilicoTrials Major Business
2.11.3 InSilicoTrials AI-Powered Drug Discovery Software Product and Solutions
2.11.4 InSilicoTrials AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 InSilicoTrials Recent Developments and Future Plans
2.12 Insilico Medicine
2.12.1 Insilico Medicine Details
2.12.2 Insilico Medicine Major Business
2.12.3 Insilico Medicine AI-Powered Drug Discovery Software Product and Solutions
2.12.4 Insilico Medicine AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Insilico Medicine Recent Developments and Future Plans
2.13 Micro Tracker
2.13.1 Micro Tracker Details
2.13.2 Micro Tracker Major Business
2.13.3 Micro Tracker AI-Powered Drug Discovery Software Product and Solutions
2.13.4 Micro Tracker AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Micro Tracker Recent Developments and Future Plans
2.14 PEPID PDC
2.14.1 PEPID PDC Details
2.14.2 PEPID PDC Major Business
2.14.3 PEPID PDC AI-Powered Drug Discovery Software Product and Solutions
2.14.4 PEPID PDC AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 PEPID PDC Recent Developments and Future Plans
2.15 厂肠丑谤枚诲颈苍驳别谤
2.15.1 厂肠丑谤枚诲颈苍驳别谤 Details
2.15.2 厂肠丑谤枚诲颈苍驳别谤 Major Business
2.15.3 厂肠丑谤枚诲颈苍驳别谤 AI-Powered Drug Discovery Software Product and Solutions
2.15.4 厂肠丑谤枚诲颈苍驳别谤 AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 厂肠丑谤枚诲颈苍驳别谤 Recent Developments and Future Plans
2.16 Thermo Scientific
2.16.1 Thermo Scientific Details
2.16.2 Thermo Scientific Major Business
2.16.3 Thermo Scientific AI-Powered Drug Discovery Software Product and Solutions
2.16.4 Thermo Scientific AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 Thermo Scientific Recent Developments and Future Plans
2.17 XtalPi
2.17.1 XtalPi Details
2.17.2 XtalPi Major Business
2.17.3 XtalPi AI-Powered Drug Discovery Software Product and Solutions
2.17.4 XtalPi AI-Powered Drug Discovery Software Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 XtalPi Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global AI-Powered Drug Discovery Software Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of AI-Powered Drug Discovery Software by Company Revenue
3.2.2 Top 3 AI-Powered Drug Discovery Software Players 麻豆原创 Share in 2023
3.2.3 Top 6 AI-Powered Drug Discovery Software Players 麻豆原创 Share in 2023
3.3 AI-Powered Drug Discovery Software 麻豆原创: Overall Company Footprint Analysis
3.3.1 AI-Powered Drug Discovery Software 麻豆原创: Region Footprint
3.3.2 AI-Powered Drug Discovery Software 麻豆原创: Company Product Type Footprint
3.3.3 AI-Powered Drug Discovery Software 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global AI-Powered Drug Discovery Software Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global AI-Powered Drug Discovery Software 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global AI-Powered Drug Discovery Software Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global AI-Powered Drug Discovery Software 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America AI-Powered Drug Discovery Software Consumption Value by Type (2019-2030)
6.2 North America AI-Powered Drug Discovery Software Consumption Value by Application (2019-2030)
6.3 North America AI-Powered Drug Discovery Software 麻豆原创 Size by Country
6.3.1 North America AI-Powered Drug Discovery Software Consumption Value by Country (2019-2030)
6.3.2 United States AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe AI-Powered Drug Discovery Software Consumption Value by Type (2019-2030)
7.2 Europe AI-Powered Drug Discovery Software Consumption Value by Application (2019-2030)
7.3 Europe AI-Powered Drug Discovery Software 麻豆原创 Size by Country
7.3.1 Europe AI-Powered Drug Discovery Software Consumption Value by Country (2019-2030)
7.3.2 Germany AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific AI-Powered Drug Discovery Software Consumption Value by Type (2019-2030)
8.2 Asia-Pacific AI-Powered Drug Discovery Software Consumption Value by Application (2019-2030)
8.3 Asia-Pacific AI-Powered Drug Discovery Software 麻豆原创 Size by Region
8.3.1 Asia-Pacific AI-Powered Drug Discovery Software Consumption Value by Region (2019-2030)
8.3.2 China AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America AI-Powered Drug Discovery Software Consumption Value by Type (2019-2030)
9.2 South America AI-Powered Drug Discovery Software Consumption Value by Application (2019-2030)
9.3 South America AI-Powered Drug Discovery Software 麻豆原创 Size by Country
9.3.1 South America AI-Powered Drug Discovery Software Consumption Value by Country (2019-2030)
9.3.2 Brazil AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa AI-Powered Drug Discovery Software Consumption Value by Type (2019-2030)
10.2 Middle East & Africa AI-Powered Drug Discovery Software Consumption Value by Application (2019-2030)
10.3 Middle East & Africa AI-Powered Drug Discovery Software 麻豆原创 Size by Country
10.3.1 Middle East & Africa AI-Powered Drug Discovery Software Consumption Value by Country (2019-2030)
10.3.2 Turkey AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE AI-Powered Drug Discovery Software 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 AI-Powered Drug Discovery Software 麻豆原创 Drivers
11.2 AI-Powered Drug Discovery Software 麻豆原创 Restraints
11.3 AI-Powered Drug Discovery Software Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 AI-Powered Drug Discovery Software Industry Chain
12.2 AI-Powered Drug Discovery Software Upstream Analysis
12.3 AI-Powered Drug Discovery Software Midstream Analysis
12.4 AI-Powered Drug Discovery Software Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
AtomWise
AutoDock
BenevolentAI
CCD Vault
Compound Assist
Cyclica
DrugDev Spark
DrugPatentWatch
DSG Drug Safety
Epocrates
InSilicoTrials
Insilico Medicine
Micro Tracker
PEPID PDC
厂肠丑谤枚诲颈苍驳别谤
Thermo Scientific
XtalPi
听
听
*If Applicable.
